- Home
- PLBC vs ITOS Comparison
PLBC vs ITOS Comparison
Compare PLBC & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- ITOS
- Stock Information
- Founded
- PLBC 1980
- ITOS 2011
- Country
- PLBC United States
- ITOS United States
- Employees
- PLBC N/A
- ITOS N/A
- Industry
- PLBC Finance Companies
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLBC Finance
- ITOS Health Care
- Exchange
- PLBC Nasdaq
- ITOS Nasdaq
- Market Cap
- PLBC 236.7M
- ITOS 270.7M
- IPO Year
- PLBC 2005
- ITOS 2020
- Fundamental
- Price
- PLBC $43.53
- ITOS $10.02
- Analyst Decision
- PLBC Buy
- ITOS Hold
- Analyst Count
- PLBC 3
- ITOS 6
- Target Price
- PLBC $57.67
- ITOS $10.60
- AVG Volume (30 Days)
- PLBC 12.1K
- ITOS 2.6M
- Earning Date
- PLBC 07-16-2025
- ITOS 04-28-2025
- Dividend Yield
- PLBC 2.76%
- ITOS N/A
- EPS Growth
- PLBC 3.33
- ITOS N/A
- EPS
- PLBC 4.95
- ITOS N/A
- Revenue
- PLBC $84,001,000.00
- ITOS $35,000,000.00
- Revenue This Year
- PLBC $19.95
- ITOS N/A
- Revenue Next Year
- PLBC $22.19
- ITOS $31.74
- P/E Ratio
- PLBC $8.80
- ITOS N/A
- Revenue Growth
- PLBC 9.14
- ITOS 177.89
- 52 Week Low
- PLBC $32.50
- ITOS $4.80
- 52 Week High
- PLBC $51.33
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- PLBC 48.47
- ITOS 73.75
- Support Level
- PLBC $43.05
- ITOS $8.30
- Resistance Level
- PLBC $44.84
- ITOS $11.35
- Average True Range (ATR)
- PLBC 1.21
- ITOS 0.53
- MACD
- PLBC -0.22
- ITOS 0.22
- Stochastic Oscillator
- PLBC 13.45
- ITOS 71.15
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.